Like 7 signifies perfection, the Apple A12 Bionic chipset released in 2018 was perfect. It was closely compared with fellow 7nm chipsets like Kirin 980 and Qualcomm Snapdragon 855 SoC. For the latter, it even supports 5G technology as can be seen in the Samsung Galaxy S10 5G model. But that’s not the bone of contention. Apple’s next 5nm chipset (first of its kind) is the centre of attraction. With the chipset likely to be named Bionic A13 SoC, Taiwan Semiconductor Manufacturing Company (TSMC) is the chosen OEM for this feat. Asides the reduction of the node’s size, what’s confirmed as its component is the extreme ultraviolet lithography (EUV). Also, it gives room for addition of more transistors. If the current Apple Bionic A12 chipset bags over 6.9 billion transistors, that of A3 can only get better. Even as the 5nm chip is in the works, Apple’s flagship phones this year will carry the Bionic A12 chip. What are your views on this? Share with us in the comments block. More on Apple news:
Apple Employs Former Samsung VP to Help Develop Batteries Apple Lowers iPhones Prices in China to Increase Demand LG is Going to Start Delivering OLED Panels for Apple’s iPhone Apple Rumoured to Launch First 5G Smartphone in 2020 Apple Mac Mini 2018 Official: Finally a Big Refresh After Four Years
